Linked Data API

Show Search Form

Search Results

77266
registered interest false more like this
date less than 2014-07-10more like thismore than 2014-07-10
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Lyme Disease more like this
house id 2 more like this
legislature
25277
pref label House of Lords remove filter
question text To ask Her Majesty’s Government what evidence existed to show that the Health Protection Agency’s Lyme Borreliosis Unit (LBU) conformed with European Union and United Kingdom legislation for the use of the Trinity Biotech kit for <i>in vitro</i> testing when used with cerebrospinal fluid; and what testing was carried out by the LBU to verify that the use of that test kit was suitable, and sufficiently sensitive, for the detection of European and United Kingdom species of Borrelia infections in cerebrospinal fluid. more like this
tabling member printed
The Countess of Mar more like this
uin HL1000 more like this
answer
answer
is ministerial correction false remove filter
date of answer less than 2014-07-24more like thismore than 2014-07-24
answer text <p>The former Health Protection Agency's Lyme Borreliosis Unit adhered to legislation related to diagnostic testing. The Trinity Biotech Lyme Western Blot technique was widely used in Europe at that time for serum and samples. Controls were run with each batch of the test to verify the tests accuracy and sensitivity. Quality assurance samples were run to ensure independent validation of the results.</p> more like this
answering member printed Earl Howe more like this
question first answered
less than 2014-07-24T14:21:30.3706696Zmore like thismore than 2014-07-24T14:21:30.3706696Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
1861
label Biography information for The Countess of Mar more like this